Therapeutic strategies targeting FOXO transcription factors

Giampaolo Calissi1, Eric W-F Lam2, Wolfgang Link3

  • 1Instituto de Investigaciones Biomédicas "Alberto Sols" (CSIC-UAM), Madrid, Spain.

Insights

Forkhead box O (FOXO) proteins regulate key cellular functions and are implicated in diseases like cancer and aging. Modulating FOXO activity offers potential therapeutic strategies for cancer treatment and promoting healthy aging.

Area of Science:

  • Molecular Biology
  • Genetics
  • Pharmacology

Background:

  • Forkhead box O (FOXO) proteins are crucial transcription factors regulating diverse physiological processes.
  • These proteins play significant roles in cellular stress response, metabolism, cell cycle arrest, and apoptosis.
  • Dysregulation of FOXO proteins is linked to major pathological conditions, including cancer, cardiovascular disease, diabetes, and neurological disorders.

Purpose of the Study:

  • To provide a comprehensive overview of the multifaceted roles of FOXO proteins in maintaining health and their involvement in disease pathogenesis.
  • To discuss current and emerging pharmacological strategies aimed at modulating FOXO protein activity for therapeutic benefit.
  • To highlight the therapeutic potential of targeting FOXO proteins for cancer treatment and the promotion of healthy aging.

Main Methods:

  • This review synthesizes existing scientific literature on FOXO proteins.
  • It examines the molecular mechanisms underlying FOXO function in various cellular contexts.
  • Pharmacological approaches targeting FOXO pathways are critically evaluated.

Main Results:

  • FOXO proteins act as context-dependent tumor suppressors, frequently inactivated in human cancers.
  • FOXO3 is identified as a key gene associated with human longevity.
  • Pharmacological modulation of FOXO proteins presents a promising therapeutic avenue.

Conclusions:

  • Targeting FOXO proteins offers a viable strategy for developing novel therapeutics.
  • Interventions aimed at modulating FOXO function hold promise for cancer treatment and enhancing healthy aging.
  • Further research into FOXO protein pharmacology is warranted to fully realize their therapeutic potential.

Related Concept Videos

Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.0K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.5K
Transcription Factors02:16

Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
81.2K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.4K
Combinatorial Gene Control02:33

Combinatorial Gene Control

Combinatorial gene control is the synergistic action of several transcriptional factors to regulate the expression of a single gene. The absence of one or more of these factors may lead to a significant difference in the level of gene expression or repression.
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
9.0K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
10.6K